OBJECTIVE: To examine the influence of incident stressful experiences on antiretroviral medication adherence and treatment outcomes. Past trauma history predicts poorer medication adherence and health outcomes. Human immunodeficiency virus (HIV)-infected individuals experience frequently traumatic and stressful events, such as sexual and physical assault, housing instability, and major financial, employment, and legal difficulties. METHODS: We measured prospectively incident stressful and traumatic events, medication adherence, and viral load over 27 months in an eight-site, five-state study. Using multivariable logistic and generalized estimating equation modeling, we assessed the impact of incident stressful events on 27-month changes in self-reported medication adherence and virologic failure (viral load = >or=400 c/mL). RESULTS: Of 474 participants on antiretroviral therapy at baseline, 289 persons were interviewed and still received treatment at 27 months. Participants experiencing the median number of incident stressful events (n = 9) had over twice the predicted odds (odds ratio = 2.32) of antiretroviral medication nonadherence at follow-up compared with those with no events. Stressful events also predicted increased odds of virologic failure during follow-up (odds ratio = 1.09 per event). CONCLUSIONS: Incident stressful events are exceedingly common in the lives of HIV-infected individuals and negatively affect antiretroviral medication adherence and treatment outcomes. Interventions to address stress and trauma are needed to improve HIV outcomes.
OBJECTIVE: To examine the influence of incident stressful experiences on antiretroviral medication adherence and treatment outcomes. Past trauma history predicts poorer medication adherence and health outcomes. Human immunodeficiency virus (HIV)-infected individuals experience frequently traumatic and stressful events, such as sexual and physical assault, housing instability, and major financial, employment, and legal difficulties. METHODS: We measured prospectively incident stressful and traumatic events, medication adherence, and viral load over 27 months in an eight-site, five-state study. Using multivariable logistic and generalized estimating equation modeling, we assessed the impact of incident stressful events on 27-month changes in self-reported medication adherence and virologic failure (viral load = >or=400 c/mL). RESULTS: Of 474 participants on antiretroviral therapy at baseline, 289 persons were interviewed and still received treatment at 27 months. Participants experiencing the median number of incident stressful events (n = 9) had over twice the predicted odds (odds ratio = 2.32) of antiretroviral medication nonadherence at follow-up compared with those with no events. Stressful events also predicted increased odds of virologic failure during follow-up (odds ratio = 1.09 per event). CONCLUSIONS: Incident stressful events are exceedingly common in the lives of HIV-infected individuals and negatively affect antiretroviral medication adherence and treatment outcomes. Interventions to address stress and trauma are needed to improve HIV outcomes.
Authors: Jonathan Shuter; Julie A Sarlo; Tina J Kanmaz; Richard A Rode; Barry S Zingman Journal: J Acquir Immune Defic Syndr Date: 2007-05-01 Impact factor: 3.731
Authors: Charles H Hinkin; David J Hardy; Karen I Mason; Steven A Castellon; Ramani S Durvasula; Mona N Lam; Marta Stefaniak Journal: AIDS Date: 2004-01-01 Impact factor: 4.177
Authors: Michael J Mugavero; Brian Wells Pence; Kathryn Whetten; Jane Leserman; Marvin Swartz; Dalene Stangl; Nathan M Thielman Journal: AIDS Patient Care STDS Date: 2007-09 Impact factor: 5.078
Authors: Jane Leserman; Brian Wells Pence; Kathryn Whetten; Michael J Mugavero; Nathan M Thielman; Marvin S Swartz; Dalene Stangl Journal: Am J Psychiatry Date: 2007-11 Impact factor: 18.112
Authors: Viviane D Lima; Josie Geller; David R Bangsberg; Thomas L Patterson; Mark Daniel; Thomas Kerr; Julio S G Montaner; Robert S Hogg Journal: AIDS Date: 2007-05-31 Impact factor: 4.177
Authors: Brian Wells Pence; Nathan M Thielman; Kathryn Whetten; Jan Ostermann; Virender Kumar; Michael J Mugavero Journal: AIDS Patient Care STDS Date: 2008-11 Impact factor: 5.078
Authors: Timothy J Arentsen; Stella Panos; April D Thames; J Natalie Arbid; Steven A Castellon; Charles H Hinkin Journal: J HIV AIDS Soc Serv Date: 2016-09-23
Authors: Kelly C Young-Wolff; Varada Sarovar; Stacy A Sterling; Amy Leibowitz; Brigid McCaw; Charles B Hare; Michael J Silverberg; Derek D Satre Journal: AIDS Care Date: 2019-03-19
Authors: Cathy M Puskas; Jamie I Forrest; Surita Parashar; Kate A Salters; Angela M Cescon; Angela Kaida; Cari L Miller; David R Bangsberg; Robert S Hogg Journal: Curr HIV/AIDS Rep Date: 2011-12 Impact factor: 5.071
Authors: Brian Wells Pence; James L Raper; Susan Reif; Nathan M Thielman; Jane Leserman; Michael J Mugavero Journal: Psychosom Med Date: 2010-07-01 Impact factor: 4.312
Authors: Inge B Corless; Joachim Voss; A J Guarino; Dean Wantland; William Holzemer; Mary Jane Hamilton; Elizabeth Sefcik; Suzanne Willard; Kenn Kirksey; Carmen Portillo; Marta Rivero Mendez; Maria E Rosa; Patrice K Nicholas; Sarie Human; Mary Maryland; Shahnaz Moezzi; Linda Robinson; Yvette Cuca Journal: J Assoc Nurses AIDS Care Date: 2013-03-07 Impact factor: 1.354
Authors: Michele R Decker; Elizabeth Miller; Heather L McCauley; Daniel J Tancredi; Heather Anderson; Rebecca R Levenson; Jay G Silverman Journal: Sex Transm Infect Date: 2013-11-14 Impact factor: 3.519